GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Price, Quote, News and Overview
NYSE:GRDN - New York Stock Exchange, Inc. - US40145W1018 - Common Stock - Currency: USD
GRDN Quote, Performance and Key Statistics
20.26
-0.07 (-0.34%)
The current stock price of GRDN is 20.26 USD. In the past month the price decreased by -2.31%.
GRDN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC | 6.1 | 10.09B | ||
| YI | 111 INC | N/A | 59.21M | ||
| MGRX | MANGOCEUTICALS INC | N/A | 20.00M | ||
| RDGT | RIDGETECH INC | N/A | 6.85M |
Related stock screener links
About GRDN
Company Profile
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. The company is headquartered in Atlanta, Georgia and currently employs 3,400 full-time employees. The company went IPO on 2024-09-26. The firm provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its services include GuardianShield, provider services, and others. Its Guardian Compass platform offers insights to enhance efficiencies for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers. The company serves assisted living and memory care, hospice care and others.
Company Info
GUARDIAN PHRMCY SERVICES-A
300 Galleria Parkway SE, Suite 800
Atlanta GEORGIA US
Employees: 3400
Phone: 14048100089
GUARDIAN PHRMCY SERVICES-A / GRDN FAQ
What is the stock price of GUARDIAN PHRMCY SERVICES-A today?
The current stock price of GRDN is 20.26 USD. The price decreased by -0.34% in the last trading session.
What is the ticker symbol for GUARDIAN PHRMCY SERVICES-A stock?
The exchange symbol of GUARDIAN PHRMCY SERVICES-A is GRDN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is GRDN stock listed?
GRDN stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for GUARDIAN PHRMCY SERVICES-A stock?
9 analysts have analysed GRDN and the average price target is 27.88 USD. This implies a price increase of 37.61% is expected in the next year compared to the current price of 20.26. Check the GUARDIAN PHRMCY SERVICES-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GUARDIAN PHRMCY SERVICES-A worth?
GUARDIAN PHRMCY SERVICES-A (GRDN) has a market capitalization of 1.28B USD. This makes GRDN a Small Cap stock.
How many employees does GUARDIAN PHRMCY SERVICES-A have?
GUARDIAN PHRMCY SERVICES-A (GRDN) currently has 3400 employees.
What are the support and resistance levels for GUARDIAN PHRMCY SERVICES-A (GRDN) stock?
GUARDIAN PHRMCY SERVICES-A (GRDN) has a support level at 20.15 and a resistance level at 20.39. Check the full technical report for a detailed analysis of GRDN support and resistance levels.
Is GUARDIAN PHRMCY SERVICES-A (GRDN) expected to grow?
The Revenue of GUARDIAN PHRMCY SERVICES-A (GRDN) is expected to grow by 10.26% in the next year. Check the estimates tab for more information on the GRDN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GUARDIAN PHRMCY SERVICES-A (GRDN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GRDN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GRDN, evaluating the profitability, health, valuation and growth aspects
- GUARDIAN PHRMCY SERVICES-A (GRDN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GUARDIAN PHRMCY SERVICES-A (GRDN) Sales and EPS estimates to see what analysts future expectations are.
- GUARDIAN PHRMCY SERVICES-A (GRDN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GUARDIAN PHRMCY SERVICES-A (GRDN) Insider and Institutional Ownership to learn about the owners and their transactions.
- GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Chart to make your own analysis
- GUARDIAN PHRMCY SERVICES-A (GRDN) Latest news and press-releases to stay up to date.
Does GUARDIAN PHRMCY SERVICES-A (GRDN) stock pay dividends?
GRDN does not pay a dividend.
When does GUARDIAN PHRMCY SERVICES-A (GRDN) report earnings?
GUARDIAN PHRMCY SERVICES-A (GRDN) will report earnings on 2025-08-11.
What is the Price/Earnings (PE) ratio of GUARDIAN PHRMCY SERVICES-A (GRDN)?
GUARDIAN PHRMCY SERVICES-A (GRDN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).
What is the Short Interest ratio of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?
The outstanding short interest for GUARDIAN PHRMCY SERVICES-A (GRDN) is 3.01% of its float. Check the ownership tab for more information on the GRDN short interest.
GRDN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GRDN.
GRDN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to GRDN. GRDN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
GRDN Financial Highlights
Over the last trailing twelve months GRDN reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -567.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.63% | ||
| ROE | -65.54% | ||
| Debt/Equity | 0 |
GRDN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to GRDN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 160% and a revenue growth 10.26% for GRDN